mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.005 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.006 |